These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 302143)

  • 21. [Side effects of high dose methotrexate with citrovorum factor therapy: relationship between clinical data and serum concentration of methotrexate].
    Watanabe M; Yanagisawa M; Sato K
    Gan To Kagaku Ryoho; 1990 May; 17(5):1081-4. PubMed ID: 2334175
    [No Abstract]   [Full Text] [Related]  

  • 22. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
    Levi M; Sulkes A; Katz E; Rizel S; Biran S
    Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter: Methotrexate with citrovorum-factor rescue.
    Falk L
    N Engl J Med; 1975 Jun; 292(26):1406-7. PubMed ID: 1079571
    [No Abstract]   [Full Text] [Related]  

  • 24. High-dose methotrexate for advanced breast cancer.
    Yap HY; Blumenschein GR; Yap BS; Hortobagyi GN; Tashima CK; Wang AY; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1979 May; 63(5):757-61. PubMed ID: 313246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient case involving high-dose methotrexate followed by leucovorin rescue.
    Alsop JA
    Am J Hosp Pharm; 1978 Feb; 35(2):127. PubMed ID: 305201
    [No Abstract]   [Full Text] [Related]  

  • 26. Recovery from toxicity associated with high-dose methotrexate: prognostic factors.
    Chan H; Evans WE; Pratt CB
    Cancer Treat Rep; 1977 Aug; 61(5):797-804. PubMed ID: 19151
    [No Abstract]   [Full Text] [Related]  

  • 27. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
    Kickinger W; Ritschl P; Kotz R
    Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
    Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
    Jaffe N
    Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved therapeutic index of methotrexate with "leucovorin rescue".
    Levitt M; Mosher MB; DeConti RC; Farber LR; Skeel RT; Marsh JC; Mitchell MS; Papac RJ; Thomas ED; Bertino JR
    Cancer Res; 1973 Jul; 33(7):1729-34. PubMed ID: 4541737
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
    Pratt CB; Roberts D; Shanks EC; Warmath EL
    Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
    Sirotnak FM; Moccio DM; Dorick DM
    Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate. II. Use in pediatric chemotherapy.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):397-413. PubMed ID: 6398630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose methotrexate with citrovorum factor rescue for patients with refractory lymphoproliferative disorders.
    Case DC
    J Maine Med Assoc; 1980 Dec; 71(12):355-8. PubMed ID: 6970790
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Methotrexate-citrovorum factor in treating osteogenic sarcoma.
    Djerassi I
    N Engl J Med; 1975 May; 292(21):1133-4. PubMed ID: 1079317
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II study of high-dose methotrexate in the treatment of patients with non-small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
    Ettinger DS; Stanley KE; Nystrom JS
    Cancer Treat Rep; 1980; 64(10-11):1017-21. PubMed ID: 6970075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
    Perez C; Wang YM; Sutow WW; Herson J
    Cancer Clin Trials; 1978; 1(2):107-11. PubMed ID: 316368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis.
    Shiroky J; Allegra C; Inghirami G; Chabner B; Yarboro C; Klippel JH
    J Rheumatol; 1988 Feb; 15(2):251-5. PubMed ID: 3258915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.
    Bertino JR
    Semin Oncol; 1977 Jun; 4(2):203-16. PubMed ID: 301662
    [No Abstract]   [Full Text] [Related]  

  • 40. High dose methotrexate with citrovorum factor in adult resistant lymphoma.
    Turman S; Coleman M; Silver RT; Pasmantier M
    Cancer; 1977 Dec; 40(6):2823-8. PubMed ID: 338137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.